The Latest in Non-Hodgkin Lymphoma

Combination offers ‘important new option’ for CLL, team says

December 13, 2015

FDA approves rapid-infusion bendamustine

December 11, 2015

Triplet disappoints in follicular lymphoma trial

December 11, 2015

2nd-gen BTK inhibitor may be safer, team says

December 10, 2015

FDA grants KTE-C19 breakthrough designation

December 10, 2015

CAR exhibits activity in resistant B-cell malignancies

December 9, 2015

Ibrutinib ‘treatment of choice’ in rel/ref MCL

December 8, 2015

Trial of ofatumumab in FL stopped early

November 25, 2015

ESRD treatments linked to different cancers

November 13, 2015

Drug ‘life-changing’ for CLL patients in phase 1 trial

November 12, 2015

Inhibitor exhibits ‘modest’ activity in lymphoma

November 12, 2015

Breast cancer drug may also work in MCL, myeloma

November 6, 2015

FDA grants drug priority review as FL therapy

November 6, 2015

Post-ibrutinib management in MCL unclear, speaker says

November 3, 2015

Reprogramming the immune system

November 1, 2015